SciClone Pharmaceuticals, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 80   

Articles published

SCLN 9.36 -0.19 (-1.99%)
price chart
Sciclone Pharmaceuticals Inc (SCLN) Discloses Form 4 Insider Selling : Exec ...
Sciclone Pharmaceuticals Inc (SCLN) Discloses Insider Transaction. Friedhelm Blobel , President & CEO of Sciclone Pharmaceuticals Inc sold 10,000 shares on Jul 17, 2015. The Insider selling transaction was disclosed on Jul 20, 2015 to the Securities ...
SciClone Pharmaceuticals Shares Down 3.1% After Insider Selling (SCLN)  Dakota Financial News
SciClone Pharmaceuticals To Report Financial Results For The Second Quarter ...
FOSTER CITY, Calif., July 23, 2015 /PRNewswire/ -- SciClone Pharmaceuticals, Inc. SCLN, -1.43% today announced that it plans to report financial results for the second quarter 2015 on Monday, August 10, 2015.
SciClone Pharmaceuticals CEO Sells $97200.00 in Stock (SCLN)  The Legacy
Why SciClone Pharmaceuticals, Inc. Is Surging Higher
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN)'s Insider Friedhelm Blobel ...
Mr. Friedhelm Blobel, the current President & CEO at SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN) 9.64 -0.15 -1.53% has not a long ago been linked with a stock market sale of 10,000 shares of the stock exchange listed company, valued at $9.7 per share ...
Company Shares of SciClone Pharmaceuticals, Inc. Rally 8.54%  American Trade Journal
Friedhelm Blobel an Insider in SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN ...
The President & CEO of SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN) 9.67 0.00 0.00% , Friedhelm Blobel recently cashed-in almost $215,912 US Dollars for 20,000 shares in the Sciclone Pharmaceuticals Inc corporation at an around $10.8 for every ...
Company Shares of SciClone Pharmaceuticals, Inc. Rally 18.16%  Insider Trading Report
SciClone Pharmaceuticals Downgraded to "Sell" at BWS Financial (SCLN)  Dakota Financial News
Friedhelm Blobel Sold 10000 Shares of SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN)
SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN) 9.67 0.00 0.00% President & CEO and an insider Friedhelm Blobel not a long ago made a sale of 10,000 company shares with a total value of $92,143 at an average price per share of $9.2.
Large Inflow of Money Witnessed in SciClone Pharmaceuticals, Inc.  Insider Trading Report
SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN) a Buy: MLV & Co  Market Report
Is SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN) Stock a Sell after Friedhelm ...
Company insider, Friedhelm Blobel, President & CEO of SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN) 9.67 0.00 0.00% sold a total of 10,000 shares of the firm, based on a stock price of $9.1 per every share.
Sciclone Pharmaceuticals Inc (SCLN) Files Form 4 Insider Selling : Chuncai ...  Insider Trading Report
Company Shares of SciClone Pharmaceuticals, Inc. Rally 0.33%  American Trade Journal
Insider Transaction: Chuncai Meng Unloaded 23660 Shares of SciClone ...
Company insider, Chuncai Meng, Gen. Counsel & VP Compliance of SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN) 9.79 0.00 % unloaded a total of 23,660 shares of the company, estimated based on $9.6 for each share.
3 Reasons SciClone Pharmaceuticals (SCLN) is a Great Value Stock
This method discovered several great candidates for value-oriented investors, but today let's focus on SciClone Pharmaceuticals, Inc. (SCLN - Snapshot Report) as this stock is looking especially impressive right now. And while there are numerous ...
Analyst Price Target Update on SciClone Pharmaceuticals, Inc.
SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN): According to 2 Analysts, The short term target price has been estimated at $ 11.25.